Better Therapeutics, Inc. (BTTX) DCF Valuation

Better Therapeutics, Inc. (BTTX) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Better Therapeutics, Inc. (BTTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Make informed investment choices with the Better Therapeutics, Inc. (BTTX) DCF Calculator! Explore real financial data from Better Therapeutics, adjust growth projections and expenses, and instantly observe how these alterations affect the intrinsic value of Better Therapeutics, Inc. (BTTX).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 FY1
2023		 FY2
2024		 FY3
2025		 FY4
2026		 FY5
2027
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -55.56 -100 0 -51.85 -51.85 -51.85 -51.85 -51.85
EBITDA -5.7 -6.2 -30.6 -38.3 .0 .0 .0 .0 .0
EBITDA, % -31672.22 -78100 100 100 0 0 0 0 0
Depreciation .1 .1 1.6 2.7 .0 .0 .0 .0 .0
Depreciation, % 400 937.5 100 100 100 100 100 100 100
EBIT -5.8 -6.3 -32.2 -41.0 .0 .0 .0 .0 .0
EBIT, % -32072.22 -79037.5 100 100 0 0 0 0 0
Total Cash .8 .1 40.6 15.7 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0
Account Receivables, % 0 0 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0 100 100 50 50 50 50 50
Accounts Payable .3 .5 1.5 3.0 .0 .0 .0 .0 .0
Accounts Payable, % 1861.11 6425 100 100 100 100 100 100 100
Capital Expenditure -2.7 -2.3 -1.1 -1.2 .0 .0 .0 .0 .0
Capital Expenditure, % -15200 -28812.5 100 100 -50 -50 -50 -50 -50
Tax Rate, % -0.01760873 -0.01760873 -0.01760873 -0.01760873 -0.01760873 -0.01760873 -0.01760873 -0.01760873 -0.01760873
EBITAT -5.8 -6.5 -32.1 -41.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -8.1 -8.5 -30.5 -37.9 -3.0 .0 .0 .0 .0
WACC, % 10.02 10.02 9.98 10.02 10.01 10.01 10.01 10.01 10.01
PV UFCF
SUM PV UFCF .0 .0 .0 .0 .0 .0 .0 .0 -2.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -3
Net Debt -1
Equity Value -2
Diluted Shares Outstanding, MM 24
Equity Value Per Share -0.08

What You Will Get

  • Editable Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Better Therapeutics, Inc. (BTTX) financial data pre-loaded to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model designed to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life BTTX Financials: Pre-filled historical and projected data for Better Therapeutics, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Better Therapeutics’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Better Therapeutics’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based BTTX DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
  3. Instant Calculations: The model automatically recalculates Better Therapeutics' intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Leverage the results to inform your investment or financial analysis.

Why Choose This Calculator for Better Therapeutics, Inc. (BTTX)?

  • User-Friendly Interface: Tailored for both novice users and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your specific analysis needs.
  • Real-Time Feedback: Observe immediate updates to Better Therapeutics' valuation as you make changes.
  • Preloaded Data: Comes equipped with Better Therapeutics' actual financial metrics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use Better Therapeutics, Inc. (BTTX)?

  • Healthcare Investors: Make informed decisions with a cutting-edge platform focused on therapeutic innovation.
  • Medical Analysts: Streamline your research with comprehensive data and insights on BTTX's product pipeline.
  • Consultants: Easily tailor presentations or reports utilizing BTTX's strategic initiatives and market potential.
  • Health Enthusiasts: Enhance your understanding of therapeutic solutions and their impact on patient care.
  • Educators and Students: Utilize BTTX as a case study in courses related to healthcare and biotechnology.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Better Therapeutics, Inc. (BTTX).
  • Real-World Data: Better Therapeutics’ historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Full annual and quarterly breakdowns for in-depth insights into Better Therapeutics’ performance.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to Better Therapeutics, Inc. (BTTX).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to Better Therapeutics, Inc. (BTTX).

No products were found matching.